Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.08 |
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.096 | 0.08 |